The estimated Net Worth of Daniel G Eramian is at least 3.55 百万$ dollars as of 20 September 2012. Daniel Eramian owns over 15,000 units of CTI BioPharma Corp stock worth over 3,221,042$ and over the last 19 years Daniel sold CTIC stock worth over 326,595$.
Daniel has made over 5 trades of the CTI BioPharma Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently Daniel sold 15,000 units of CTIC stock worth 40,200$ on 20 September 2012.
The largest trade Daniel's ever made was selling 250,000 units of CTI BioPharma Corp stock on 16 December 2010 worth over 90,000$. On average, Daniel trades about 19,780 units every 42 days since 2006. As of 20 September 2012 Daniel still owns at least 354,350 units of CTI BioPharma Corp stock.
You can see the complete history of Daniel Eramian stock trades at the bottom of the page.
Daniel's mailing address filed with the SEC is 501 ELLIOTT AVE. W., SUITE #400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over 80,110,449$ worth of CTI BioPharma Corp stock and bought 9,566,060 units worth 25,487,533$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of 1,223,687$. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth 71,666$.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: